Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 47335-902

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 47335-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg

The text is a medication label for Quetiapine tablets. It includes the National Drug Code (NDC), dosage information (100 tablets), and instructions for pharmacists to dispense the medication guide to each patient.*

FDA Label Image

200 mg

This is a medication guide for Quetiapine tablets containing 10-200 mg of quetiapine fumarate. The suitable dosage is recommended in the accompanying prescribing information. It is important to store the medication at a temperature range of 20°C to 25°C and not to allow children to reach it. The medication guide can be obtained via a link mentioned in the text. Pharmacist must dispense the medication guide to each patient. The manufacturer is Sun Pharmaceutical Industries Ltd with an address in India, and the distributor is Sun Pharmaceutical Industries, Inc. However, there is a typo in the company's name as "Phamaceutical".*

FDA Label Image

25mg (25mg)

This is a label for Quetiapine Tablets, USP with an NDC number of 47335-902-88. The pharmacist is instructed to dispense medication with a guide for each patient. The label contains the prescription information, including that it is RX only and there are 100 tablets. There is also a code at the bottom of the label: DNH/DRUGS/NH/138 PGLB0609D.*

FDA Label Image

300 mg

Each film-coated tablet contains 300 mg of quetiapine fumarate, USP. It is recommended to refer to the accompanying Prescribing Information for the usual dosage. The medication should be kept out of the reach of children and stored at controlled room temperature. A medication guide is available at an indicated website. The product is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Industries Ltd. The NDC number is 47335-906-88. Pharmacists are advised to dispense medication with a guide to each patient.*

FDA Label Image

400 mg

Each tablet contains 400 mg of quetiapine fumarate. Dosage instructions are available in the accompanying Prescribing Information. Keep out of reach of children. Store between 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F). The Medication Guide can be found at 'https://www.sunpharma.convusa/products'. The tablets are dispensed with a Medication Guide to each patient. This drug is available only with a prescription. The tablets are distributed by Sun Pharmaceutical Industries, Inc. They are manufactured by Sun Pharmaceutical Industries Ltd. located in India.*

FDA Label Image

50 mg

This is a label for Quetiapine Tablets, USP with a strength of 50 mg, which is available in a bottle containing 100 tablets. The pharmacist is advised to dispense the tablets with a Medication Guide to each patient. It is available only with a prescription and the NDC code is 47335-903-88. The remaining text cannot be evaluated as it contains non-English characters and appears to be a product code.*

FDA Label Image

Quetiapine-fig-1 (Quetiapine Fig 1)

The text describes a figure (Figure 1) that illustrates Kaplan-Meier curves showing the time to recurrence of a mood event in a study labeled as Study 7. The graph shows the proportion of patients experiencing relapse with percentages on the y-axis and the time in weeks on the x-axis. Two treatments are compared: QTP + LIVAL and PLA+LIVAL, with the former showing a lower proportion of patients experiencing relapse over time.*

FDA Label Image

Quetiapine-fig-2 (Quetiapine Fig 2)

The image is a Kaplan-Meier curve illustrating the time to recurrence of a mood event in Study 8. The x-axis represents time in weeks, while the y-axis represents the proportion of patients with relapse. There are two curves displayed, one for patients treated with QTP+LIVAL and one for patients treated with PLA+LIVAL. The proportion of patients with relapse is higher in the PLA+LIVAL group.*

FDA Label Image

Quetiapine-structure (Quetiapine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.